Back
Sage Therapeutics Stock Price Chart
Sponsored
SAGE
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
34
SAGE
Sage Therapeutics
Last Price:
$5.47
Seasonality Move:
0.25%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
The current trend is relatively stagnant and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.4 | Buy |
20-day SMA: | 5.49 | Buy |
50-day SMA: | 6.08 | Sell |
200-day SMA: | 10.31 | Sell |
8-day EMA: | 5.36 | Buy |
20-day EMA: | 5.49 | Buy |
50-day EMA: | 6.05 | Sell |
200-day EMA: | 10.88 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 50.27 | Buy |
Chaikin Money Flow: | 4207089 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.05 - 5.69) | Buy |
Bollinger Bands (100): | (5.7 - 8.24) | Sell |
Sage Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 5.61 while SAGE 8-day simple moving average is 5.40, which is a Buy signal.
-
The stock price of SAGE is 5.61 while Sage Therapeutics 20-day SMA is 5.49, which makes it a Buy.
-
Sage Therapeutics 50-day simple moving average is 6.08 while SAGE share price is 5.61, making it a Sell technically.
-
SAGE stock price is 5.61 and Sage Therapeutics 200-day simple moving average is 10.31, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $5.61. The Score for SAGE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
343.2M
Price in USD:
5.61
Share Volume:
4.3M
Sage Therapeutics 52-Week Range
52-Week High:
28.26
52-Week Low:
4.62
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 5.61 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 5.61 while SAGE 8-day exponential moving average is 5.36, which is a Buy signal.
-
The stock price of SAGE is 5.61 while Sage Therapeutics 20-day EMA is 5.49, which makes it a Buy.
-
Sage Therapeutics 50-day exponential moving average is 6.05 while SAGE share price is 5.61, making it a Sell technically.
-
SAGE stock price is 5.61 and Sage Therapeutics 200-day simple moving average is 10.88, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.10 per share, and an increase next year of $2.77 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Sage Therapeutics is a Sell
-
Sage Therapeutics Relative Strength Index (RSI) is 50.27, which suggest Sage Therapeutics is overbought
-
The Bollinger Bands (25) for Sage Therapeutics is (5.05 - 5.69), which suggest Sage Therapeutics is a Sell
-
The Bollinger Bands (100) for Sage Therapeutics is (5.7 - 8.24), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.